Literature DB >> 21108037

Monitoring systemic oxidative stress in an animal model of amyotrophic lateral sclerosis.

Francisco Javier Miana-Mena1, Cristina González-Mingot, Pilar Larrodé, María Jesús Muñoz, Sara Oliván, Lorena Fuentes-Broto, Enrique Martínez-Ballarín, Russel J Reiter, Rosario Osta, Joaquín José García.   

Abstract

A mutant form of the ubiquitous copper/zinc superoxide dismutase (SOD1) protein has been found in some patients with amyotrophic lateral sclerosis (ALS). We monitored oxidative stress in an animal model of ALS, the SOD(G93A) mouse, which develops a disease similar to ALS with an accelerated course. The aim of this work was to show that ALS damages several organs and tissues, from an oxidative stress point of view. We measured lipid and protein oxidative damage in different tissue homogenates of SOD(G93A) mice. The biomarkers that we analyzed were malondialdehyde + 4-hydroxyalkenal (MDA + 4-HDA) and carbonyls, respectively. The spinal cord and brain of SOD(G93A) mice showed increased lipid peroxidation after 100 or 130 days compared to age-matched littermate controls. The CNS was most affected, but lipid peroxidation was also detected in the skeletal muscle and liver on day 130. No changes were observed in protein carbonylation in the homogenates. Our results are consistent with a multisystem etiology of ALS and suggest that oxidative stress may play a primary role in ALS pathogenesis. Thus, oxidative stress represents a potential biomarker that might be useful in developing new therapeutic strategies for ALS.

Entities:  

Mesh:

Year:  2010        PMID: 21108037     DOI: 10.1007/s00415-010-5825-8

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  47 in total

Review 1.  DNA damage by oxygen-derived species. Its mechanism and measurement in mammalian systems.

Authors:  B Halliwell; O I Aruoma
Journal:  FEBS Lett       Date:  1991-04-09       Impact factor: 4.124

2.  Increased 3-nitrotyrosine and oxidative damage in mice with a human copper/zinc superoxide dismutase mutation.

Authors:  R J Ferrante; L A Shinobu; J B Schulz; R T Matthews; C E Thomas; N W Kowall; M E Gurney; M F Beal
Journal:  Ann Neurol       Date:  1997-09       Impact factor: 10.422

3.  An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria.

Authors:  P C Wong; C A Pardo; D R Borchelt; M K Lee; N G Copeland; N A Jenkins; S S Sisodia; D W Cleveland; D L Price
Journal:  Neuron       Date:  1995-06       Impact factor: 17.173

4.  Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases.

Authors:  D Frey; C Schneider; L Xu; J Borg; W Spooren; P Caroni
Journal:  J Neurosci       Date:  2000-04-01       Impact factor: 6.167

5.  Increased oxidative damage to DNA in an animal model of amyotrophic lateral sclerosis.

Authors:  Norberto Aguirre; M Flint Beal; Wayne R Matson; Mikhail B Bogdanov
Journal:  Free Radic Res       Date:  2005-04

6.  Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase.

Authors:  H X Deng; A Hentati; J A Tainer; Z Iqbal; A Cayabyab; W Y Hung; E D Getzoff; P Hu; B Herzfeldt; R P Roos
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

7.  A genetic fusion GDNF-C fragment of tetanus toxin prolongs survival in a symptomatic mouse ALS model.

Authors:  J Ciriza; M Moreno-Igoa; A C Calvo; G Yague; J Palacio; F J Miana-Mena; M J Muñoz; P Zaragoza; P Brûlet; R Osta
Journal:  Restor Neurol Neurosci       Date:  2008       Impact factor: 2.406

8.  Accumulation of SOD1 mutants in postnatal motoneurons does not cause motoneuron pathology or motoneuron disease.

Authors:  Maria Maddalena Lino; Corinna Schneider; Pico Caroni
Journal:  J Neurosci       Date:  2002-06-15       Impact factor: 6.167

Review 9.  Relevance of oxidative injury in the pathogenesis of motor neuron diseases.

Authors:  Jeff Agar; Heather Durham
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2003-12

10.  The mitochondrial production of reactive oxygen species in relation to aging and pathology.

Authors:  Maria Luisa Genova; Milena Merlo Pich; Andrea Bernacchia; Cristina Bianchi; Annalisa Biondi; Carla Bovina; Anna Ida Falasca; Gabriella Formiggini; Giovanna Parenti Castelli; Giorgio Lenaz
Journal:  Ann N Y Acad Sci       Date:  2004-04       Impact factor: 5.691

View more
  14 in total

1.  RBM45 Modulates the Antioxidant Response in Amyotrophic Lateral Sclerosis through Interactions with KEAP1.

Authors:  Nadine Bakkar; Arianna Kousari; Tina Kovalik; Yang Li; Robert Bowser
Journal:  Mol Cell Biol       Date:  2015-05-04       Impact factor: 4.272

2.  Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent.

Authors:  Tomonori Aoyama; Yong-Han Paik; Sumio Watanabe; Benoît Laleu; Francesca Gaggini; Laetitia Fioraso-Cartier; Sophie Molango; Freddy Heitz; Cédric Merlot; Cédric Szyndralewiez; Patrick Page; David A Brenner
Journal:  Hepatology       Date:  2012-12       Impact factor: 17.425

3.  FUS(1-359) transgenic mice as a model of ALS: pathophysiological and molecular aspects of the proteinopathy.

Authors:  Sergei Y Funikov; Alexander P Rezvykh; Pavel V Mazin; Alexey V Morozov; Andrey V Maltsev; Maria M Chicheva; Ekaterina A Vikhareva; Mikhail B Evgen'ev; Aleksey A Ustyugov
Journal:  Neurogenetics       Date:  2018-07-07       Impact factor: 2.660

4.  Blood volatile organic compounds as potential biomarkers for amyotrophic lateral sclerosis: an animal study in the SOD1 G93A mouse.

Authors:  Hongquan Jiang; Changsong Wang; Ming Ren; Xiang Yin; Chunjie Chi; Lei Guo; Chaofu Ke; Honglin Feng; Enyou Li
Journal:  J Mol Neurosci       Date:  2014-04-09       Impact factor: 3.444

5.  Amyotrophic lateral sclerosis: update and new developments.

Authors:  Ashley J Pratt; Elizabeth D Getzoff; J Jefferson P Perry
Journal:  Degener Neurol Neuromuscul Dis       Date:  2012-02

Review 6.  Role of NADPH oxidases in liver fibrosis.

Authors:  Yong-Han Paik; Jonghwa Kim; Tomonori Aoyama; Samuele De Minicis; Ramon Bataller; David A Brenner
Journal:  Antioxid Redox Signal       Date:  2014-01-24       Impact factor: 8.401

Review 7.  SOD1 and TDP-43 animal models of amyotrophic lateral sclerosis: recent advances in understanding disease toward the development of clinical treatments.

Authors:  Peter I Joyce; Pietro Fratta; Elizabeth M C Fisher; Abraham Acevedo-Arozena
Journal:  Mamm Genome       Date:  2011-06-26       Impact factor: 2.957

8.  Seeking homeostasis: temporal trends in respiration, oxidation, and calcium in SOD1 G93A Amyotrophic Lateral Sclerosis mice.

Authors:  Cameron W Irvin; Renaid B Kim; Cassie S Mitchell
Journal:  Front Cell Neurosci       Date:  2015-07-01       Impact factor: 5.505

9.  Lack of association between nuclear factor erythroid-derived 2-like 2 promoter gene polymorphisms and oxidative stress biomarkers in amyotrophic lateral sclerosis patients.

Authors:  Annalisa LoGerfo; Lucia Chico; Loredana Borgia; Lucia Petrozzi; Anna Rocchi; Antonia D'Amelio; Cecilia Carlesi; Elena Caldarazzo Ienco; Michelangelo Mancuso; Gabriele Siciliano
Journal:  Oxid Med Cell Longev       Date:  2014-02-09       Impact factor: 6.543

10.  The peroxisome proliferator-activated receptor γ (PPARγ) controls natural protective mechanisms against lipid peroxidation in amyotrophic lateral sclerosis.

Authors:  Valeria Benedusi; Francesca Martorana; Liliana Brambilla; Adriana Maggi; Daniela Rossi
Journal:  J Biol Chem       Date:  2012-08-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.